Literature DB >> 2802217

Effect of volatile anesthetics on synaptic transmission in the rat hippocampus.

R A Pearce1, J L Stringer, E W Lothman.   

Abstract

The synaptic effects of halothane, isoflurane, and enflurane were examined in the rat hippocampus in vivo and compared with the effects of ketamine and urethane. Actions of the agents on excitatory amino acid-mediated neurotransmission were studied by observing evoked responses and long-term potentiation in the stratum pyramidale of CA1 with stimulation of the contralateral CA3 region. Long-term potentiation is a long-lasting increase in synaptic efficacy, which follows a brief stimulus train. It has been shown to be established through activation of the NMDA subclass of excitatory amino acid receptors and is thought to be involved in memory processing. Volatile anesthetics had no effect on evoked excitatory responses or on long-term potentiation. Actions of the anesthetics on inhibitory processes in the hippocampus were studied by pairing stimuli at a range of interpulse intervals. The first stimulus activated inhibitory processes that caused the response to the second stimulus to be smaller than the initial response, a phenomenon termed paired pulse depression. Paired pulse depression was significantly prolonged by the volatile anesthetics compared with that under urethane or ketamine. These results indicate that the mechanism of action of the volatile anesthetics at the hippocampal CA1 synapse does not involve amino acid-mediated excitation but does involve enhancement of inhibition.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2802217     DOI: 10.1097/00000542-198910000-00019

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


  17 in total

1.  Membrane and synaptic actions of halothane on rat hippocampal pyramidal neurons and inhibitory interneurons.

Authors:  K Nishikawa; M B MacIver
Journal:  J Neurosci       Date:  2000-08-15       Impact factor: 6.167

Review 2.  Preemptive analgesia: the prevention of neurogenous orofacial pain.

Authors:  P A Foreman
Journal:  Anesth Prog       Date:  1995

3.  Potentiation by sevoflurane of the gamma-aminobutyric acid-induced chloride current in acutely dissociated CA1 pyramidal neurones from rat hippocampus.

Authors:  J Wu; N Harata; N Akaike
Journal:  Br J Pharmacol       Date:  1996-11       Impact factor: 8.739

4.  Regional differences in the effects of isoflurane on neurotransmitter release.

Authors:  Robert I Westphalen; No-Bong Kwak; Keir Daniels; Hugh C Hemmings
Journal:  Neuropharmacology       Date:  2011-05-30       Impact factor: 5.250

5.  Examining the neural targets of the AMPA receptor potentiator LY404187 in the rat brain using pharmacological magnetic resonance imaging.

Authors:  Nicholas Jones; Michael J O'Neill; Mark Tricklebank; Vincenzo Libri; Steve C R Williams
Journal:  Psychopharmacology (Berl)       Date:  2005-09-14       Impact factor: 4.530

Review 6.  How we recall (or don't): the hippocampal memory machine and anesthetic amnesia.

Authors:  Misha Perouansky; Robert A Pearce
Journal:  Can J Anaesth       Date:  2010-12-18       Impact factor: 5.063

7.  GABAA receptor alpha5 subunits contribute to GABAA,slow synaptic inhibition in mouse hippocampus.

Authors:  Ewa D Zarnowska; Ruth Keist; Uwe Rudolph; Robert A Pearce
Journal:  J Neurophysiol       Date:  2008-12-10       Impact factor: 2.714

8.  Isoflurane inhibits nicotinic acetylcholine receptor-mediated 22Na+ influx and muscarinic receptor-evoked cyclic GMP production in cultured bovine adrenal medullary cells.

Authors:  K Minami; N Yanagihara; Y Toyohira; M Tsutsui; A Shigematsu; A Wada; F Izumi
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1994-03       Impact factor: 3.000

9.  Enhancement of gamma-aminobutyric acid-activated Cl- currents in cultured rat hippocampal neurones by three volatile anaesthetics.

Authors:  M V Jones; P A Brooks; N L Harrison
Journal:  J Physiol       Date:  1992-04       Impact factor: 5.182

10.  Abused inhalants enhance GABA-mediated synaptic inhibition.

Authors:  M Bruce MacIver
Journal:  Neuropsychopharmacology       Date:  2009-06-03       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.